LARS JOHAN MATERSTVEDT, Ph.D. (dr.art.)
Professor of Philosophy & in Medical Ethics


[scroll down]
RESEARCH


____________________________________________________________________________________________________________


From 1992 to 1996 I was Doctoral Fellow, The Ethics Programme,
The Research Council of Norway. Subsequent to receiving a PhD in political philosophy in 1997, on Robert Nozick (1938–2002) and Immanuel Kant (1724–1804) – see my homepage's entry on Nozick for further detail – my research was since 1999 within medical ethics (a subcategory of applied ethics); however, I left this field mid 2020. Currently my research is within experimental moral philosophy.
Skjermbilde 2021-05-03 kl. 18.25.04Skjermbilde 2021-05-03 kl. 18.24.27

As a Postdoctoral Fellow with The Norwegian Cancer Society, I carried out research on the relationship between palliative care and assisted dying, which included conducting interviews with terminally ill cancer patients who were inpatients at a palliative medicine unit about their attitudes towards, and wishes for, euthanasia and physician-assisted suicide. Medical supervisor was oncologist and professor of palliative medicine Stein Kaasa, with whom I have several publications.

5819190_3221114 kreftforeningen_logo_engelsk_skjerm_rgb-940x450

September 2017 to July 2018 I was Visiting Professor, University of Glasgow, Scotland, participating in the research project «Rejection, collaboration or integration? A comparative analysis of palliative care and assisted dying in three locations: Oregon, USA; Flanders, Belgium; and Québec, Canada». This project ended March 2020, and was carried out by members of the University of Glasgow End of Life Studies Group – headed by Professor David Clark (see also https://davidgrahamclark.net and https://twitter.com/dumfriesshire) – located on Dumfries Campus in Southern Scotland.


dg

uni-of-glasgow-white

Skjermbilde 2021-01-12 kl. 01.57.16

Across the years, my research within medical ethics also dealt with ethical and clinical issues related to withholding or withdrawing life-sustaining treatment in the seriously ill (non-treatment decisions; NTDs); ethical, clinical and philosophical aspects of the last-resort treatment strategy terminal/palliative sedation in the imminently dying; the concept of futile treatment; the intersections between health law and medical ethics; and the ethics of organ donation.